Fennec Pharmaceuticals Ord Shs T.FRX

Alternate Symbol(s): FENC

Healthcare Biotechnology

Fennec Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company focused on its product candidate PEDMARK. It sells its product through a field force, including Regional Pediatric Oncology Specialists and medical science liaisons who are helping to educate the medical communities and patients about cisplatin induced ototoxicity and its programs supporting patient access to PEDMARK. PEDMARK is a Food and Drug Administration approved therapy indicated to reduce the risk of ototoxicity associated with cisplatin treatment in pediatric patients with localized, non-metastatic, solid tumors. It is a formulation of sodium thiosulfate in single-dose, ready-to-use vials for intravenous use in pediatric patients. PEDMARK is a therapeutic agent with a dosing paradigm, across two open-label, randomized Phase 3 clinical studies, the Clinical Oncology Group (COG) Protocol ACCL0431 and SIOPEL 6. It has established Fennec HEARS, a single source program designed to connect PEDMARK patients.

TSX:FRX - Post by User

Fennec Pharmaceuticals Ord Shs

Bullboard Posts

Comment by dollarhunteron Aug 14, 2006 10:11pm

181 Views

Post# 11226084

RE: Buy of the century?? Or down the flusher?

Hey Chasio, I haven't posted in months but will let everyone know that I'm still holding a position with AHX [going on five years now] and just recently decided to "add" to my position [some may call it averaging down]. I feel too strongly in my gut that if these guys can survive through the numerous phases involved with developing a product and they succeed in marketing it then a winner we will finally have. Regards, DH

Bullboard Posts

10 best-performing AI stocks for Canadian investors